JPRN-UMIN000013719
Completed
未知
Coronary intervention and optimal AntiPlatelet Therapy-Optical coherence tomography study- - CAPTO study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Osaka General Medical Center
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with cardiovascular shock 2\) Patients with a history of stent thrombosis 3\) Patients who is impossible to be followed up at our institute 4\) Patients scheduled to have PCI or bypass surgery 5\) Patients who are treated with thienopyridine for secondary prevention of cerebrovascular event 6\) Pregnant or possibly pregnant 7\) Life expectancy \<1 year 8\) Patients after PCI 9\) Patients who were judged inappropriate by the principal investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Optimum platelet inhibition after coronary artery bypass surgery: a prospective, randomised trial comparing platelet aggregation using low- and medium-dose aspirin and clopidogrelCoronary artery bypass grafting (CABG)SurgeryISRCTN55334531Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)108
Active, not recruiting
Phase 1
DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial InjuryStable coronary artery disease.MedDRA version: 17.0 Level: PT Classification code 10011078 Term: Coronary artery disease System Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2014-000952-26-GBniversity of Edinburgh202
Not yet recruiting
Not Applicable
Assessing Optimal percutaneous coronary Intervention for LMCA RegistryJPRN-UMIN000014706Kyoto University2,000
Not yet recruiting
Not Applicable
Tailored versus Conventional Antiplatelet Strategy intended After Optimized Drug Eluting StentDiseases of the circulatory systemKCT0007408Asan Medical Center3,944
Completed
Phase 4
Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 PolymorphismMyocardial InfarctionNCT00915733Gyeongsang National University Hospital80